Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
1256MO Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours
2024
17 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
7.40
1256MO Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours | Researchclopedia
Georgetown University Medical Center
M. Nagasaka
·
University of California, Irvine
S.C-H. Kao
·
Chris O’Brien Lifehouse
Eudald Felip
·
Vall d'Hebron Hospital Universitari
Anthonie J. van der Wekken
·
University Medical Center Groningen
C.-C. Lin
·
National Taiwan University Hospital
J.R. Bauman
·
Fox Chase Cancer Center
S. Gadgeel
·
Henry Ford Health System
Manoj Samant
·
Covalent Associates (United States)
Jiayu Shen
·
Biostats (United States)
Yun Sun
·
Whalen Biomedical
Viola W. Zhu
·
Covalent Associates (United States)
Vipul Upadhyay
·
Covalent Associates (United States)
W. Marston Linehan
·
Massachusetts General Hospital